AI-powered precision medicine in haematology: insights from South Korea

M.KimM.Kim
BulletArticle
RED 2023 Artificial Intelligence
共享以下内容：
复制链接
AI-powered precision medicine in haematology: insights from South Korea

AI-driven precision haematology tailors treatments for blood disorders in healthcare, employing data-driven insights and predictive analytics to aid in diagnosis, treatment, and monitoring. In this talk at RED 2023, Dr Myungshin Kim, a Professor in the Department of Lab Medicine at Seoul St Mary’s Hospital in South Korea, shares her ongoing research in this area and what it says about the broader trend in the AI-driven transformation of medicine.

共享以下内容：
复制链接

有关同一主题的更多信息

Metabolism in precision medicine: small molecules unlock opportunities

Dr John Ward on expanding HCV testing to achieve elimination goals

推荐主题

定序RED 2020Rare Diseases
下次阅读
  • C-Suite Perspectives, Event Coverage, Healthcare Transformation, Management, RED 2024
Dr William Morice II’s visions and considerations for building a global diagnostics ecosystem
How Awanui Group drives diagnostic excellence in New Zealand: Q&A with Anoop Singh (Part 1)
  • C-Suite Perspectives, Leaders In Conversation, Management
Awanui Group’s quest to improve lab diagnostics in New Zealand: Q&A with Anoop Singh (Part 1)
‘Real world evidence’ and clinical labs: a brief introduction
  • Healthcare Transformation, Management, Operations, Population Health Management
‘Real world evidence’ and clinical labs: a brief introduction
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
  • Disease Area, Healthcare Transformation, Histopathology, Leaders In Conversation, Management, Oncology, Operations
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
Scroll to Top